查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970934

複方樟腦軟膏市場－全球產業規模、佔有率、趨勢、機會、預測：按應用、配方、地區和競爭格局分類，2021-2031年

Compound Camphor Ointment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Formulation, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球複方樟腦軟膏市場預計將從 2025 年的 29.8 億美元成長到 2031 年的 39.8 億美元，複合年成長率為 4.93%。

這些外用藥物通常含有樟腦、薄荷醇和精油，旨在緩解肌肉疼痛、呼吸道充血和皮膚發炎。其成長主要受慢性皮膚病日益增多以及全球老化人口對非侵入性止痛方式的需求所驅動。例如，美國皮膚病學會2024年報告稱，美國約有1,980萬成年人患有異位性皮膚炎，凸顯了龐大的消費群對有效止痛藥的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 29.8億美元
市場規模：2031年 39.8億美元
複合年成長率：2026-2031年 4.93%
成長最快的細分市場 緩解疼痛
最大的市場 北美洲

然而，由於嚴格的監管安全標準和毒性擔憂，市場面臨許多障礙。由於高濃度樟腦可能對健康造成不良影響，監管機構實施了嚴格的劑量限制和強制性警告標籤。這些嚴格的合規要求推高了產品開發成本，限制了配方多樣性，阻礙了產品在安全監管嚴格的地區快速進入市場和擴張。

市場促進因素

皮膚感染疾病和疾病的日益增多是市場成長的主要驅動力，也因此對便捷的局部治療方法產生了強勁的需求。樟腦因其抗菌和止癢特性而備受推崇，是緩解銀屑病、真菌感染疾病和濕疹相關症狀的軟膏中的關鍵成分。由於環境因素和免疫系統挑戰，這些疾病的發病率不斷上升，因此對有效症狀管理的需求也日益成長。根據美國國家銀屑病基金會於2024年9月發布的《銀屑病健康指標報告》，全球約有1.25億人患有銀屑病，凸顯了開發緩解慢性發炎和搔癢的局部治療方案的緊迫性。

同時，老年人口的不斷成長，尤其是那些更容易出現肌肉骨骼疼痛的老年人，顯著推動了複方樟腦軟膏需求的成長。老年人經常出現關節僵硬和關節炎，導致對非處方非鴉片類鎮痛藥的需求增加，而樟腦在這些藥物中發揮強效抗興奮劑和促進血液循環的作用。美國疾病管制與預防中心（CDC）在其2024年12月發布的《疾病與死亡率週報》中指出，美國成年人慢性疼痛的盛行率已上升至24.3%，凸顯了人們對便捷止痛治療的高度依賴。這種強勁的需求也體現在企業的業績上；例如，Hopper公司於2024年2月發布的2023年度報告顯示，其醫療保健部門（包括樟腦類鎮痛藥）的收入成長了30.1%，達到2.135億新元。

市場挑戰

全球複方樟腦軟膏市場主要受嚴格的安全法規和毒性擔憂限制。由於樟腦在高濃度下具有強效神經毒性，因此需要進行嚴格的監測，尤其是在兒童中，以防止癲癇發作等不利事件。這些安全風險迫使衛生當局實施嚴格的合規措施，包括設定活性成分濃度的上限和強制要求貼上警告標籤。因此，製造商面臨更高的研發成本，因為他們必須進行廣泛的安全性分析，以確保其配方保持在狹窄的治療範圍內。

這種監管措施對市場准入構成重大障礙，限制了配方柔軟性，導致關鍵地區的產品上市延遲。近期業界數據顯示，大量止痛藥中毒病例報告也印證了這種嚴格監管的必要性。根據美國毒物資訊中心於2024年12月發布的《2023年度報告》，止痛藥（包括樟腦類止痛藥在內的主要類別）是人類中毒病例中最常見的物質，佔所有報告病例的11.00%。如此高的發生率持續對監管施加壓力，限制樟腦類軟膏的快速成長。

市場趨勢

隨著消費者越來越重視合成潔淨標示成分標籤，產品研發也隨之變革時期。製造商正逐步拋棄人工防腐劑和傳統的凡士林基產品，轉而採用植物來源的替代品，以吸引那些關注化學毒性的健康消費者。外用產品安全性和成分透明度的需求不斷成長，進一步加速了這一趨勢。根據美國國家護膚基金會（NSF）於2025年3月開展的“個人護理產品消費者價值觀調查”，74%的消費者在購買個人保健產品時優先考慮有機成分，企業也正在重新配製傳統的樟腦軟膏，以符合天然標準並贏得消費者的信任。

同時，市場正擺脫對老年疼痛管理的傳統依賴，策略性地拓展至運動表現提升和運動後復原領域。各大品牌正將樟腦類鎮痛藥重新定義為「運動前熱身」和「運動後肌肉恢復」的必備輔助產品，有效吸引了活躍的年輕消費者。這種向生活​​方式導向用途的轉變正在產生顯著的商業性動力，並凸顯了對能夠提升運動表現的恢復輔助產品的需求。例如，久光製藥株式會社在其2024年12月發布的《2024年綜合報告》中指出，其面向活躍人群的非處方藥（OTC）部門的國內銷售額同比成長35.9%，表明該領域已成功從純粹的醫療應用發展成為更廣泛的運動和健康解決方案。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球樟腦軟膏市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依用途分類（緩解疼痛、真菌感染疾病、止癢、其他）
    • 依劑型（口服、外用）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美複方樟腦軟膏市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲複方樟腦軟膏市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區復方樟腦軟膏市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲複合樟腦軟膏市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美複方樟腦軟膏市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球複方樟腦軟膏市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • PerkinElmer, Inc.
  • Agilent Technologies, Inc
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffman-La Roche Ltd..
  • NeoGenomics Laboratories, Inc.
  • Advanced Cell Diagnostics, Inc
  • Abbott Laboratories Inc.
  • Regeneron Pharmaceuticals Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23833

The Global Compound Camphor Ointment Market is projected to expand from USD 2.98 Billion in 2025 to USD 3.98 Billion by 2031, reflecting a compound annual growth rate of 4.93%. These topical pharmaceutical preparations, typically formulated with camphor alongside menthol and essential oils, are designed to relieve muscular pain, respiratory congestion, and skin irritation. Growth is largely sustained by the increasing incidence of chronic dermatological conditions and the needs of an aging global population seeking non-invasive pain relief. For example, the American Academy of Dermatology reported in 2024 that approximately 19.8 million adults in the United States suffered from atopic dermatitis, underscoring the significant consumer base reliant on effective soothing agents.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.98 Billion
Market Size 2031USD 3.98 Billion
CAGR 2026-20314.93%
Fastest Growing SegmentPain Relief
Largest MarketNorth America

However, the market faces substantial hurdles due to stringent regulatory safety standards and concerns regarding toxicity. Because high concentrations of camphor can cause adverse health effects, authorities enforce rigorous dosage caps and mandatory warning labels. These strict compliance mandates elevate product development costs and limit formulation versatility, ultimately hindering rapid market entry and expansion in regions with intense safety oversight.

Market Driver

The rising prevalence of skin infections and dermatological disorders acts as a major engine for market growth, creating a strong need for accessible topical treatments. Valued for its antimicrobial and antipruritic capabilities, camphor is a critical component in ointments aimed at alleviating symptoms linked to psoriasis, fungal infections, and eczema. As environmental factors and immune system challenges cause these conditions to become more common, the call for effective symptom management grows louder. According to the 'Psoriasis Health Indicator Report' published by the National Psoriasis Foundation in September 2024, psoriasis affects roughly 125 million individuals globally, highlighting the urgent requirement for topical solutions that soothe chronic inflammation and itching.

In parallel, the expanding geriatric population, which is prone to musculoskeletal pain, significantly drives the uptake of compound camphor ointments. Older demographics frequently experience joint stiffness and arthritis, fueling the demand for over-the-counter, non-opioid analgesic options where camphor acts as a potent counter-irritant to boost blood flow. The Centers for Disease Control and Prevention noted in their December 2024 'Morbidity and Mortality Weekly Report' that chronic pain prevalence among U.S. adults has climbed to 24.3%, emphasizing the reliance on accessible pain therapies. This strong demand is evident in corporate results; for instance, Haw Par Corporation's 'Annual Report 2023', released in February 2024, revealed that revenue from its Healthcare segment, which comprises camphor-based analgesics, rose by 30.1% to SGD 213.5 million.

Market Challenge

The expansion of the Global Compound Camphor Ointment Market is significantly impeded by stringent safety regulations and concerns regarding toxicity. Since camphor acts as a potent neurotoxin at high concentrations, rigorous oversight is required to prevent adverse outcomes like seizures, especially among pediatric groups. These safety dangers force health authorities to implement strict compliance measures, such as imposing caps on active ingredient percentages and requiring mandatory warning labels. Consequently, manufacturers face inflated research and development expenses as they must perform extensive safety profiling to guarantee that formulations stay within narrow therapeutic boundaries.

Such regulatory scrutiny acts as a formidable barrier to market entry and limits the flexibility of formulations, thereby delaying product launches in critical regions. The necessity for this rigorous surveillance is highlighted by recent industrial data showing a high volume of exposures to pain-relief substances. According to the 2023 Annual Report from America's Poison Centers, published in December 2024, analgesics-the primary category containing camphor-based pain relief products-were the most frequent substance class involved in human exposures, representing 11.00% of all reported cases. This high incidence rate perpetuates the regulatory pressure that constrains the rapid growth of camphor-based ointments.

Market Trends

The rise of paraben-free and clean-label formulations is transforming product development as consumers increasingly examine ingredient lists for synthetic additives. Manufacturers are shifting away from artificial preservatives and traditional petrolatum bases, opting instead for plant-derived alternatives to attract health-conscious buyers worried about chemical toxicity. This trend is fueled by a growing preference for safety and ingredient transparency in topical products. According to the 'Consumer Values in Personal Care Survey' by NSF in March 2025, 74% of consumers now prioritize organic ingredients when buying personal care items, prompting companies to reformulate legacy camphor ointments to meet natural standards and secure consumer trust.

Concurrently, the market is strategically expanding into the athletic performance and sports recovery sectors, moving beyond its traditional dependence on geriatric pain management. Brands are rebranding camphor-based analgesics as vital aids for pre-workout warming and post-exercise muscle recovery, effectively appealing to younger, active consumers. This shift toward lifestyle-focused applications has created substantial commercial momentum, confirming the demand for recovery aids that enhance performance. For example, Hisamitsu Pharmaceutical Co., Inc. reported in its December 2024 'Integrated Report 2024' that domestic sales within its over-the-counter pharmaceuticals division, which serves this active demographic, grew by 35.9% year-over-year, illustrating the sector's successful evolution from strictly medicinal uses to broader athletic wellness solutions.

Key Market Players

  • PerkinElmer, Inc.
  • Agilent Technologies, Inc
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffman-La Roche Ltd..
  • NeoGenomics Laboratories, Inc.
  • Advanced Cell Diagnostics, Inc
  • Abbott Laboratories Inc.
  • Regeneron Pharmaceuticals Inc.

Report Scope

In this report, the Global Compound Camphor Ointment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Compound Camphor Ointment Market, By Application

  • Pain Relief
  • Fungal Infection
  • Anti-itching
  • Others

Compound Camphor Ointment Market, By Formulation

  • Internal Use
  • Topical Use

Compound Camphor Ointment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Compound Camphor Ointment Market.

Available Customizations:

Global Compound Camphor Ointment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Compound Camphor Ointment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Pain Relief, Fungal Infection, Anti-itching, Others)
    • 5.2.2. By Formulation (Internal Use, Topical Use)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Compound Camphor Ointment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Formulation
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Compound Camphor Ointment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Formulation
    • 6.3.2. Canada Compound Camphor Ointment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Formulation
    • 6.3.3. Mexico Compound Camphor Ointment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Formulation

7. Europe Compound Camphor Ointment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Formulation
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Compound Camphor Ointment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Formulation
    • 7.3.2. France Compound Camphor Ointment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Formulation
    • 7.3.3. United Kingdom Compound Camphor Ointment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Formulation
    • 7.3.4. Italy Compound Camphor Ointment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Formulation
    • 7.3.5. Spain Compound Camphor Ointment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Formulation

8. Asia Pacific Compound Camphor Ointment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Formulation
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Compound Camphor Ointment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Formulation
    • 8.3.2. India Compound Camphor Ointment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Formulation
    • 8.3.3. Japan Compound Camphor Ointment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Formulation
    • 8.3.4. South Korea Compound Camphor Ointment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Formulation
    • 8.3.5. Australia Compound Camphor Ointment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Formulation

9. Middle East & Africa Compound Camphor Ointment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Formulation
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Compound Camphor Ointment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Formulation
    • 9.3.2. UAE Compound Camphor Ointment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Formulation
    • 9.3.3. South Africa Compound Camphor Ointment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Formulation

10. South America Compound Camphor Ointment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Formulation
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Compound Camphor Ointment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Formulation
    • 10.3.2. Colombia Compound Camphor Ointment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Formulation
    • 10.3.3. Argentina Compound Camphor Ointment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Formulation

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Compound Camphor Ointment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. PerkinElmer, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Agilent Technologies, Inc
  • 15.3. Merck & Co., Inc.
  • 15.4. Pfizer, Inc.
  • 15.5. Bio-Rad Laboratories, Inc.
  • 15.6. F. Hoffman-La Roche Ltd..
  • 15.7. NeoGenomics Laboratories, Inc.
  • 15.8. Advanced Cell Diagnostics, Inc
  • 15.9. Abbott Laboratories Inc.
  • 15.10. Regeneron Pharmaceuticals Inc.

16. Strategic Recommendations

17. About Us & Disclaimer